- CORT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Corcept Therapeutics (CORT) 8-K30 Oct 24Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results from Phase 3 Gradient Trial In Patients with Cushing’s SyndromeFinancial data
Company Profile